Research study Program year 2021 Source: CMS Open Payments

A Phase 2, Multicenter, Global, Randomized, Double

Research payments

$770,772

17 payments

Through program year 2021, $770,772 in research payments was reported against A Phase 2, Multicenter, Global, Randomized, Double, across 17 payments, paid by Celgene Corporation.

Paid by: Celgene Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$770,772	17

Breakdown

Who paid Research payments · program year 2021

Celgene Corporation $770,772 17 payments

Who received the money Research payments · program year 2021

Physicians Research Group Organisation paid for research $117,410 2 payments
Dominion Med Associates Organisation paid for research $93,309 1 payment
Burke Pharmaceutical Research Organisation paid for research $88,846 1 payment
First Oc Dermatology Organisation paid for research $70,323 1 payment
Forcare Clinical Research Organisation paid for research $66,710 1 payment
Oregon Medical Research Center Organisation paid for research $49,190 1 payment
Vial Health Technology Inc. Organisation paid for research $48,609 1 payment
Aeroallergy Research Laboratory Organisation paid for research $44,908 1 payment
Metabolic Research Institute, INC Organisation paid for research $44,667 1 payment
Clinical Research Center Of Alabama Organisation paid for research $42,440 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.